Grufity logoGrufity logo

BAX

52.38USD-3.86(-6.86%)Market Closed

Baxter International Inc

Market Summary

USD52.38-3.86Market Closed
-6.86%

BAX Alerts

BAX Stock Price

RSI Chart

Valuation

Market Cap

27.7B

Price/Earnings

-11.66

Price/Sales

1.88

Price/Cashflow

18.91

MarketCap/EBT

-12.07

Price/Sales

Profitability

EBT Margin

-15.56%

Return on Equity

-42.59%

Return on Assets

-8.5%

Fundamentals

Revenue

Revenue (TTM)

14.7B

Revenue Y/Y

16.96%

Revenue Q/Q

0.72%

Earnings

Earnings (TTM)

-2.4B

Earnings Y/Y

-752.67%

Earnings Q/Q

-1.3K%

Price Action

52 Week Range

49.8389.06
(Low)(High)

Last 7 days

-7.0%

Last 30 days

-2.5%

Last 90 days

-6.8%

Trailing 12 Months

-29.5%

Financial Health

Current Ratio

2.11

Debt/Equity

2

Debt/Cashflow

0.1

Investor Care

Dividend Yield

2.07%

Dividend/Share (TTM)

1.14

Shares Dilution (1Y)

0.68%

Diluted EPS (TTM)

-4.72

Peers (Alternatives to Baxter International)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
10.2T
429.9M
-13.56% 48.60%
185.5K
28.0K
144.70% 331.94%
86.7B
17.9B
9.40% 1.57%
41.71
4.92
7.67% 29.32%
86.3B
6.1B
11.19% -14.20%
62.6
14.1
11.47% -18.42%
67.1B
18.9B
7.25% 7.47%
38.21
3.25
-6.81% -14.96%
61.8B
12.3B
7.86% 20.92%
69.9
5.01
10.11% 51.89%
43.9B
5.4B
6.85% -27.80%
30.09
8.18
5.29% -1.25%
MID-CAP
6.7B
998.4M
12.82% 19.67%
44.21
6.87
6.04% -19.01%
6.4B
806.4M
29.82% -13.72%
-331.15
7.96
20.10% -221.96%
3.9B
380.1M
-14.51% 1.73%
-29.57
10.69
18.85% -63.58%
3.6B
790.7M
-23.89% -65.81%
-273.58
4.7
19.65% -412.22%
SMALL-CAP
1.6B
126.8M
20.67% 27.67%
-26.38
14.01
34.44% -10.05%
1.1B
291.9M
5.19% 0.37%
-6.57
3.67
52.45% -57.74%
1.0B
795.9M
20.86% -8.66%
-131.34
1.33
8.11% 182.50%
606.7M
236.2M
-3.52% -27.68%
-16.43
2.57
-8.79% -175.19%

Financials for Baxter International

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue3.9%14,74014,19313,54512,78412,451
Gross Profit-3.4%5,3405,5285,3085,1054,890
  S&GA Expenses7.4%3,8603,5933,2922,8672,632
  R&D Expenses4.1%588565556534531
Earnings Before Taxes-304.3%-2,294.001,1231,2201,4771,404
Net Income-335.0%-2,376.001,0111,0571,2841,214
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-12.1%27,96531,83132,71633,52119,807
  Current Assets-0.9%7,8107,8828,1738,8728,167
    Cash Equivalents-13.6%1,6001,8522,3003,0003,300
  Inventory0.5%2,6752,6632,5482,4532,025
  Net PPE-3.6%4,7994,9765,1145,1784,582
  Goodwill-31.2%6,6399,6449,8169,8363,098
Liabilities-2.4%22,38622,92823,59724,40010,992
  Current Liabilities-5.3%3,7083,9163,8904,2363,441
.    Short Term Borrowings37.5%275200200301301
  Long Term Debt-17,754----
Shareholder's Equity-37.0%5,5798,8599,0759,0778,770
  Retained Earnings-18.0%14,01517,09916,99417,06516,967
  Additional Paid-In Capital0.7%6,2536,2076,1976,131-
Accumulated Depreciation-3.7%6,2856,5286,6436,5506,589
Shares Outstanding0.2%504503500--
Minority Interest0%4444444445
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-20.8%1,4651,8502,0532,2222,241
  Share Based Compensation6.7%175164156146126
Cashflow From Investing0.2%-10,942.00-10,965.00-10,966.00-11,200.00-1,197.00
Cashflow From Financing0.3%7,9577,9358,0558,245-2,174.00
  Dividend Payments3.1%562545530515
  Buy Backs-8.6%32353476001,100

Risks

What is the probability of a big loss on BAX?

26.5%


Probability that Baxter International stock will be more than 20% underwater in next one year

6.9%


Probability that Baxter International stock will be more than 30% underwater in next one year.

1.5%


Probability that Baxter International stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does BAX drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Baxter International was unfortunately bought at previous high price.

Returns

Cumulative Returns on BAX

5.6%


10-Year Cumulative Returns

6.3%


7-Year Cumulative Returns

-3.3%


5-Year Cumulative Returns

-12.8%


3-Year Cumulative Returns

What are the long-term rolling returns for BAX?

FIve years rolling returns for Baxter International.

Which funds bought or sold BAX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-29
London & Capital Asset Management Ltd
REDUCED
-11.31
-265,000
770,000
0.07%
2022-11-23
Eagle Bay Advisors LLC
ADDED
41.3
3,227
18,000
0.01%
2022-11-23
Aurora Investment Counsel
SOLD OFF
-100
-2,628,000
-
-%
2022-11-23
Toroso Investments, LLC
ADDED
3.07
-49,000
315,000
0.01%
2022-11-22
IHT Wealth Management, LLC
ADDED
23.58
11,000
333,000
0.03%
2022-11-22
B. Riley Wealth Advisors, Inc.
REDUCED
-16.02
-179,000
425,000
0.01%
2022-11-22
CVA Family Office, LLC
REDUCED
-75.41
-16,000
4,000
-%
2022-11-22
Dash Acquisitions Inc.
ADDED
8.75
-486,000
5,026,000
2.81%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
8,315,000
8,315,000
0.10%
2022-11-21
FourThought Financial, LLC
UNCHANGED
-
-5,000
25,000
-%

1–10 of 46

Latest Funds Activity

Are funds buying BAX calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own BAX

Baxter International News

MarketWatch

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day.11 hours ago

BAX Fair Value

Recent SEC filings of Baxter International

View All Filings
Date Filed Form Type Document
Oct 27, 2022
8-K
Current Report
Oct 27, 2022
10-Q
Quarterly Report
Sep 06, 2022
4
Insider Trading

Latest Insider Trading transactions for BAX

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-09-01
Borzi James W
SOLD (Taxes)
-263,877
56.76
-4,649
SVP, Global Supply Chain
2022-06-01
Rosenbloom David S.
ACQUIRED
-
-
41,576
SVP and General Counsel
2022-05-10
WILVER PETER M
ACQUIRED
-
-
2,481
-
2022-05-10
Shafer David Brent
ACQUIRED
-
-
2,481
-
2022-05-03
Mahoney Michael F
ACQUIRED
-
-
2,706
-
2022-05-03
SCHLICHTING NANCY M
ACQUIRED
-
-
2,706
-
2022-05-03
Chen Thomas F
ACQUIRED
-
-
2,706
-
2022-05-03
MORRISON PATRICIA
ACQUIRED
-
-
2,706
-
2022-05-03
Oesterle Stephen N.
ACQUIRED
-
-
2,706
-
2022-05-03
HELLMAN PETER S
ACQUIRED
-
-
2,706
-

1–10 of 50

José E. Almeida
60000
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

BAX Income Statement

2022-09-30
Condensed Consolidated Statements of Income (Loss) (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Net sales$ 3,773$ 3,226$ 11,226$ 9,270
Cost of sales2,6401,9057,2925,571
Gross margin1,1331,3213,9343,699
Selling, general and administrative expenses9476802,9751,982
Research and development expenses152129450396
Goodwill impairments2,78502,7850
Other operating expense (income), net48(1)20(6)
Operating income (loss)(2,799)513(2,296)1,327
Interest expense, net10450278118
Other (income) expense, net6312315
Income (loss) before income taxes(2,966)451(2,577)1,194
Income tax expense (benefit)(32)(1)29141
Net income (loss)(2,934)452(2,606)1,053
Net income attributable to noncontrolling interests3287
Net income (loss) attributable to Baxter stockholders$ (2,937)$ 450$ (2,614)$ 1,046
Earnings (loss) per share    
Basic (in dollars per share)$ (5.83)$ 0.90$ (5.20)$ 2.08
Diluted (in dollars per share)$ (5.83)$ 0.89$ (5.20)$ 2.06
Weighted-average number of shares outstanding    
Basic (in shares)504500503503
Diluted (in shares)504506503509

BAX Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 1,601$ 2,951
Accounts receivable, net of allowances of $120 in 2022 and $122 in 20212,5552,629
Inventories2,6752,453
Prepaid expenses and other current assets979839
Total current assets7,8108,872
Property, plant and equipment, net4,7995,178
Goodwill6,6399,836
Other intangible assets, net6,9277,792
Operating lease right-of-use assets546630
Other non-current assets1,2441,213
Total assets27,96533,521
Current liabilities:  
Short-term debt275301
Current maturities of long-term debt and finance lease obligations4210
Accounts payable1,2341,246
Accrued expenses and other current liabilities2,1952,479
Total current liabilities3,7084,236
Long-term debt and finance lease obligations, less current portion16,15317,149
Operating lease liabilities454522
Other non-current liabilities2,0712,493
Total liabilities22,38624,400
Commitments and contingencies
Equity:  
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2022 and 2021683683
Common stock in treasury, at cost,179,451,293 shares in 2022 and 181,879,516 shares in 2021(11,406)(11,488)
Additional contributed capital6,2976,197
Retained earnings14,01517,065
Accumulated other comprehensive income (loss)(4,054)(3,380)
Total Baxter stockholders’ equity5,5359,077
Noncontrolling interests4444
Total equity5,5799,121
Total liabilities and equity$ 27,965$ 33,521